- List
- By Topic
- On Map
- Search Details

Slovakia (1579 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03830424 | Not yet recruiting New |
Assessment of Autonomic Nervous Regulation During Postnatal Period in Newborns |
|
|
Observational |
|
Other |
|
|
75 | All | up to 4 Days (Child) | NCT03830424 | EK69/2018 | February 15, 2019 | October 1, 2020 | December 31, 2020 | February 5, 2019 | February 5, 2019 |
|
||||
2 | NCT03511924 | Recruiting | Intradialytic Resistance Training in Haemodialysis Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
50 | All | 30 Years and older (Adult, Older Adult) | NCT03511924 | PJSU-JR | IRTHEP | January 11, 2018 | June 30, 2019 | December 31, 2019 | April 30, 2018 | February 12, 2019 |
|
||
3 | NCT03403777 | Active, not recruiting | Avelumab in Refractory Testicular Germ Cell Cancer. |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
8 | Male | 18 Years and older (Adult, Older Adult) | NCT03403777 | NCISlovakia | November 15, 2017 | February 28, 2019 | February 28, 2020 | January 19, 2018 | February 5, 2019 |
|
|||
4 | NCT03329053 | Recruiting | Utilization of Physical Activity Recommendations Among Patients of Cardiovascular Healthcare Centres in Eastern Slovakia |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
400 | All | 40 Years to 75 Years (Adult, Older Adult) | NCT03329053 | PJSU-1/0825/17 | AWATAR | February 23, 2018 | December 2018 | December 2018 | November 1, 2017 | March 7, 2018 |
|
||
5 | NCT03282682 | Recruiting | Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
36 | Male | 45 Years to 60 Years (Adult) | NCT03282682 | FSPORT-CU-ADAM | October 1, 2017 | October 31, 2018 | December 31, 2018 | September 14, 2017 | August 14, 2018 |
|
|||
6 | NCT03212131 | Completed | Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function. |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
34 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03212131 | NN8640-4298 U1111-1187-9247 2016-003911-36 |
August 16, 2017 | March 8, 2018 | March 8, 2018 | July 11, 2017 | March 22, 2018 |
|
|||
7 | NCT03203096 | Completed | Magnesium Supplementation in Stress Conditions |
|
|
Interventional |
Not Applicable |
|
Industry / Other |
|
|
70 | All | 18 Years and older (Adult, Older Adult) | NCT03203096 | StressMag2017 | January 15, 2017 | June 6, 2017 | June 6, 2017 | June 29, 2017 | June 29, 2017 |
|
|||
8 | NCT03105232 | Recruiting | Opioid-Redox Study |
|
Observational |
|
Other |
|
|
300 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03105232 | N28/11/16 | ORS | August 20, 2018 | May 1, 2019 | May 1, 2020 | April 7, 2017 | August 1, 2018 |
|
||||
9 | NCT03055559 | Completed | Trial Protocol GlobiFer - Oral Iron Repletion |
|
|
Observational |
|
Other |
|
|
60 | Female | 18 Years to 60 Years (Adult) | NCT03055559 | Not identified | TPG | June 2016 | May 4, 2017 | May 4, 2017 | February 16, 2017 | March 14, 2018 |
|
|||
10 | NCT03052595 | Recruiting | Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance |
|
|
Observational |
|
Other |
|
|
70 | All | 18 Years to 45 Years (Adult) | NCT03052595 | APVV 15-0228 | MS-MIDY | February 1, 2017 | June 30, 2020 | December 31, 2021 | February 14, 2017 | December 13, 2018 |
|
|||
11 | NCT03039296 | Recruiting | EuroPainClinics® Study IV (Prospective Observational Study) |
|
|
Observational |
|
Other |
|
|
150 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03039296 | 5N/2016 | EPCSIV | February 3, 2017 | January 1, 2020 | December 31, 2021 | February 1, 2017 | February 11, 2019 |
|
|||
12 | NCT02860819 | Recruiting | Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
43 | Male | 18 Years and older (Adult, Older Adult) | NCT02860819 | GCTSK004 | July 2016 | December 2018 | December 2018 | August 9, 2016 | August 22, 2018 |
|
|||
13 | NCT02837939 | Recruiting | Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
124 | All | 18 Years and older (Adult, Older Adult) | NCT02837939 | IMUNO - HEGITO 7 | IMUNO-HEGITO7 | July 2016 | July 2020 | July 2020 | July 20, 2016 | September 20, 2017 |
|
||
14 | NCT02835781 | Completed | Acellular Dermal Matrix in Breast Reconstruction |
|
|
Observational |
|
Other |
|
|
30 | Female | 18 Years to 60 Years (Adult) | NCT02835781 | UHB/006/2015/MB | Adermbrerec | January 2010 | January 2014 | June 2016 | July 18, 2016 | July 18, 2016 |
|
|||
15 | NCT02819960 | Recruiting | Prevention of Irinotecan Induced Diarrhea by Probiotics |
|
|
Interventional |
Phase 3 |
|
Industry / Other |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT02819960 | 2 | March 2016 | July 2020 | December 2020 | June 30, 2016 | January 17, 2019 |
|
|||
16 | NCT02769559 | Completed | Reduction Mammaplasty and Improved Quality of Life |
|
|
Observational |
|
Other |
|
|
52 | Female | 18 Years to 63 Years (Adult) | NCT02769559 | UHB/005/2015/MB | MammaRed | January 2000 | December 2014 | May 2016 | May 11, 2016 | May 12, 2016 |
|
|||
17 | NCT02742311 | Recruiting | EuroPainClinics® Study V (Prospective Observational Study) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
500 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02742311 | EK: 9N-2015 | EPCSV | January 2016 | May 2018 | January 2019 | April 19, 2016 | July 31, 2018 |
|
||
18 | NCT02693769 | Terminated | A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils |
|
|
Interventional |
Phase 2 Phase 3 |
|
Industry |
|
|
2 | All | 40 Years and older (Adult, Older Adult) | NCT02693769 | KFL3503 | July 2016 | October 2016 | December 2016 | February 29, 2016 | December 12, 2016 |
|
|||
19 | NCT02544685 | Active, not recruiting | Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
120 | All | 6 Months to 19 Years (Child, Adult) | NCT02544685 | 1 | FENSY | July 2010 | September 2019 | October 2019 | September 9, 2015 | January 17, 2019 |
|
||
20 | NCT02414685 | Recruiting | First Line TIP in Poor Prognosis TGCTs. |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
37 | Male | 18 Years and older (Adult, Older Adult) | NCT02414685 | GCTSK003 | TIP | April 2015 | December 2019 | December 2019 | April 13, 2015 | January 4, 2018 |
|
||
21 | NCT02351050 | Completed | Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
144 | All | 35 Years to 90 Years (Adult, Older Adult) | NCT02351050 | 13595 | April 2015 | September 2017 | November 2017 | January 30, 2015 | March 26, 2018 |
|
|||
22 | NCT02325804 | Unknown † | Effect of Specific Diet and Physical Activity on Weight and/or Fat Loss |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
60 | All | 18 Years to 50 Years (Adult) | NCT02325804 | FEXE- 11/2014 | December 2014 | December 2016 | December 2017 | December 25, 2014 | April 27, 2016 |
|
|||
23 | NCT02216370 | Unknown † | Detection of Occult Paroxysmal AF in Cryptogenic Stroke or TIA Patients Using an Implantable Loop Recorder and Correlation With Genetic Markers. |
|
Observational |
|
Other |
|
|
125 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02216370 | NRRXT0001 | April 2014 | June 2018 | June 2018 | August 13, 2014 | August 13, 2014 |
|
|||||
24 | NCT02055612 | Completed | Mobile Clinic - a Cross-sectional Epidemiological Survey |
|
Observational |
|
Industry |
|
|
3278 | All | 55 Years and older (Adult, Older Adult) | NCT02055612 | CRFB002ASK01 EPI | March 2013 | May 2013 | July 2013 | February 5, 2014 | March 1, 2017 |
|
|||||
25 | NCT02026856 | Completed | Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis |
|
|
Observational |
|
Other |
|
|
4 | All | 20 Years to 80 Years (Adult, Older Adult) | NCT02026856 | Se-AOX 109/2011 | Se-AOX | December 2013 | December 2013 | December 2013 | January 3, 2014 | April 10, 2017 |
|
|||
26 | NCT02023398 | Completed | BTL-9000 High Frequency Therapy for the Waist Circumferential Reduction |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
102 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02023398 | BTL-9000 HFT | September 2013 | December 2013 | December 2013 | December 30, 2013 | September 19, 2014 |
|
|||
27 | NCT01862978 | Unknown † | Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
150 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01862978 | MTSVKNEUROL001 | Heparinas | May 2013 | May 2015 | December 2015 | May 27, 2013 | August 15, 2013 |
|
||
28 | NCT01800981 | Unknown † | Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care |
|
Observational |
|
Industry |
|
|
53 | All | 10 Years to 61 Years (Child, Adult) | NCT01800981 | MW2012-12-12 | March 2013 | July 2013 | February 28, 2013 | February 28, 2013 |
|
||||||
29 | NCT01788098 | Completed | Genetics and Mechanisms of Rheumatoid Arthritis |
|
Observational |
|
Other |
|
|
790 | All | 18 Years and older (Adult, Older Adult) | NCT01788098 | RASGENAS ATMOS N00024 |
RASGENAS | October 2009 | June 2012 | December 2012 | February 11, 2013 | February 11, 2013 |
|
||||
30 | NCT01579461 | Completed | A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
32 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01579461 | 178-CL-039 2008-000210-77 |
November 2008 | April 2009 | April 2009 | April 18, 2012 | September 5, 2013 |
|
|||
31 | NCT01548248 | Completed | Efficacy and Safety of Levemir® Used as Basal Insulin |
|
|
Observational |
|
Industry |
|
|
631 | All | Child, Adult, Older Adult | NCT01548248 | NN304-1928 | January 2006 | October 2006 | October 2006 | March 8, 2012 | January 31, 2017 |
|
||||
32 | NCT01542489 | Completed | Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos |
|
|
Observational |
|
Industry |
|
|
480 | All | Child, Adult, Older Adult | NCT01542489 | NN304-1927 | October 2006 | April 2007 | April 2007 | March 2, 2012 | January 31, 2017 |
|
||||
33 | NCT01536639 | Completed | Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes |
|
|
Observational |
|
Industry |
|
|
454 | All | Child, Adult, Older Adult | NCT01536639 | BIASP-1929 | January 2006 | December 2006 | December 2006 | February 22, 2012 | January 9, 2017 |
|
||||
34 | NCT01516242 | Completed | Evaluation of Safety and Parameters of Application Technique |
|
|
Observational |
|
Industry |
|
|
4819 | All | Child, Adult, Older Adult | NCT01516242 | MS236-1926 | October 2006 | December 2007 | December 2007 | January 24, 2012 | November 7, 2016 |
|
||||
35 | NCT01466231 | Completed | Everolimus in Refractory Testicular Germ Cell Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
15 | Male | 18 Years and older (Adult, Older Adult) | NCT01466231 | GCTSK002 | November 2011 | June 2015 | June 2015 | November 7, 2011 | January 12, 2016 |
|
|||
36 | NCT01449500 | Unknown † | Supplementation With L. Reuteri in H. Pylori Infected Adults |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
56 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01449500 | CSUB0028 | October 2011 | April 2012 | April 2012 | October 10, 2011 | October 10, 2011 |
|
|||
37 | NCT01444833 | Unknown † | Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
35 | Male | 25 Years to 50 Years (Adult) | NCT01444833 | MinHealth 2007/27-SAV-02 |
ADIRAS | October 2008 | March 2009 | December 2012 | October 3, 2011 | October 3, 2011 |
|
||
38 | NCT01405599 | Completed | Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
32 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01405599 | NPJ5004-01/2011 (HEP) | June 2011 | October 2011 | October 2011 | July 29, 2011 | October 16, 2012 |
|
|||
39 | NCT01400984 | Completed | To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia |
|
|
Observational |
|
Industry |
|
|
92 | All | 2 Years to 18 Years (Child, Adult) | NCT01400984 | EMR200104-526 | ECOS SVK | December 31, 2011 | December 31, 2015 | December 31, 2015 | July 25, 2011 | December 26, 2017 |
|
|||
40 | NCT01350700 | Completed | Long Term Follow up of Scars Formation and Quality of Life Assessment Study |
|
|
Observational |
|
Industry |
|
|
148 | All | 4 Years to 55 Years (Child, Adult) | NCT01350700 | MW2012-01-02 | June 2011 | November 2011 | November 22, 2011 | May 10, 2011 | November 1, 2017 |
|
||||
41 | NCT01217879 | Completed | COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia |
|
|
Observational |
|
Industry |
|
|
980 | All | 18 Years and older (Adult, Older Adult) | NCT01217879 | 15379 KL0910SK 14881 - KL0910PL GM.2009-04-06.0017 |
COUGH | January 2010 | September 2010 | September 2010 | October 8, 2010 | November 16, 2012 |
|
|||
42 | NCT01010503 | Completed Has Results |
A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis. |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
32 | All | 18 Years and older (Adult, Older Adult) | NCT01010503 | ML22508 2009-011520-53 |
June 2009 | May 2010 | May 2010 | November 10, 2009 | August 13, 2014 | August 13, 2014 |
|
||
43 | NCT00976326 | Completed | A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver Function |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
12 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00976326 | NN1250-1989 2009-009465-34 |
August 2009 | March 2010 | March 2010 | September 14, 2009 | January 20, 2017 |
|
|||
44 | NCT00872066 | Completed | A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip Replacement |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
243 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00872066 | CT02/11 | March 2006 | July 2016 | July 2016 | March 31, 2009 | March 3, 2017 |
|
|||
45 | NCT00687284 | Completed | Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus |
|
|
Observational |
|
Industry |
|
|
2188 | All | Child, Adult, Older Adult | NCT00687284 | NN304-3515 | START | February 2008 | June 2010 | June 2010 | May 30, 2008 | October 28, 2016 |
|
|||
46 | NCT00676741 | Completed | Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin |
|
|
Observational |
|
Industry |
|
|
3809 | All | 18 Years and older (Adult, Older Adult) | NCT00676741 | BIASP-3516 | COMMIT | February 2008 | May 2010 | May 2010 | May 13, 2008 | October 31, 2016 |
|
|||
47 | NCT00635674 | Completed | Effects of CPAP on Cardiovascular Risk in Obstructive Sleep Apnea (OSA) and Metabolic Syndrome |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
32 | All | 35 Years to 75 Years (Adult, Older Adult) | NCT00635674 | OSAMSCPAP | February 2007 | February 2008 | February 2008 | March 14, 2008 | March 14, 2008 |
|
|||
48 | NCT00490711 | Completed | Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
7 | Female | 18 Years to 75 Years (Adult, Older Adult) | NCT00490711 | 4720 B9E-MC-S205 |
July 2003 | April 2005 | June 25, 2007 | June 25, 2007 |
|
||||
49 | NCT00315718 | Completed | Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2) |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
10 | All | 45 Years to 80 Years (Adult, Older Adult) | NCT00315718 | HPC-02/1998 | June 2002 | June 2005 | April 19, 2006 | April 19, 2006 |
|
||||
50 | NCT00158769 | Completed | A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
16 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00158769 | EMD10007 | March 31, 2005 | October 26, 2005 | October 26, 2005 | September 12, 2005 | September 25, 2017 |
|
|||
51 | NCT00130949 | Completed | ALGRX 4975 in the Treatment of Tennis Elbow |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
45 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00130949 | 4975-2-005-2 Eudra CT No : 2004-001000-12 |
November 2004 | November 2005 | August 17, 2005 | December 20, 2006 |
|
||||
52 | NCT03557398 | Completed | Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
40 | Female | 45 Years to 75 Years (Adult, Older Adult) | NCT03557398 | QQ53-17-01 | November 29, 2017 | May 29, 2018 | May 29, 2018 | June 15, 2018 | June 15, 2018 |
|
|||
53 | NCT02314598 | Active, not recruiting | Therapy Coil Electrogram Collection Study |
|
|
Observational |
|
Industry |
|
|
46 | All | 18 Years and older (Adult, Older Adult) | NCT02314598 | TEC Study | TEC | January 2015 | September 20, 2017 | October 20, 2017 | December 11, 2014 | June 20, 2017 |
|
|||
54 | NCT02253732 | Completed | Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 60 Years to 85 Years (Adult, Older Adult) | NCT02253732 | UEE-SAS | Brain-Muscle | September 2015 | September 2017 | March 2018 | October 1, 2014 | April 17, 2018 |
|
||
55 | NCT02165826 | Completed Has Results |
Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
1323 | All | 40 Years and older (Adult, Older Adult) | NCT02165826 | RO-2455-302-RD U1111-1150-2477 2013-001788-21 |
OPTIMIZE | May 1, 2014 | September 1, 2015 | September 1, 2015 | June 18, 2014 | April 20, 2017 | March 14, 2017 |
|
|
56 | NCT02011100 | Completed | Effect of Carnosine on Diabetes and Cardiovascular Risk Factors |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
28 | All | 25 Years to 50 Years (Adult) | NCT02011100 | CarnoDMCVD | Carnorisk | December 2013 | December 2017 | March 2018 | December 13, 2013 | April 17, 2018 |
|
||
57 | NCT00796718 | Completed Has Results |
A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
62 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT00796718 | ML21800 2008-003980-38 |
October 2008 | August 2010 | August 2010 | November 24, 2008 | August 25, 2016 | August 25, 2016 |
|
||
58 | NCT03440125 | Completed | Cayenne Pepper Cataplasm - Safety Study |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT03440125 | UP-MunariStudy | Munari04 | March 15, 2016 | November 15, 2016 | December 15, 2016 | February 20, 2018 | February 20, 2018 |
|
||
59 | NCT03277274 | Completed | A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous (IV) TAK-954 |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
26 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03277274 | TAK-954-1006 2017-000714-37 U1111-1196-9190 |
November 9, 2017 | September 1, 2018 | September 10, 2018 | September 11, 2017 | September 14, 2018 |
|
|||
60 | NCT02705209 | Completed | Cayenne Pepper Cataplasm - Effect Study |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
20 | All | 50 Years to 65 Years (Adult, Older Adult) | NCT02705209 | Munari02 | October 2015 | December 2015 | February 2016 | March 10, 2016 | March 10, 2016 |
|
|||
61 | NCT02621047 | Completed Has Results |
Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
28 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02621047 | NP29783 2015-002976-25 |
December 4, 2015 | December 8, 2016 | December 8, 2016 | December 3, 2015 | August 24, 2018 | August 24, 2018 |
|
||
62 | NCT01888393 | Completed | Study of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and Healthy Subjects |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
23 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01888393 | VX13-809-010 | June 2013 | November 2013 | November 2013 | June 27, 2013 | November 19, 2013 |
|
|||
63 | NCT01679977 | Completed | Vibrational-proprioceptive Resistance Exercise Training Versus Neuromuscular Electrical Stimulation Training in Elderly People With Muscle Weakness |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
150 | All | 65 Years to 85 Years (Older Adult) | NCT01679977 | MOBIL | MOBIL | June 2008 | December 2014 | March 2015 | September 6, 2012 | March 7, 2016 |
|
||
64 | NCT01577680 | Completed | A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
18 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01577680 | 114637 | March 5, 2012 | June 29, 2012 | June 29, 2012 | April 16, 2012 | July 25, 2017 |
|
|||
65 | NCT00932867 | Completed | Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment |
|
|
Observational |
|
Industry |
|
|
3114 | All | 18 Years and older (Adult, Older Adult) | NCT00932867 | 14010 14010 - KL0711SK 14327 - KL0711RO |
SONAR | December 2007 | June 2008 | August 2009 | July 3, 2009 | April 20, 2010 |
|
|||
66 | NCT00653978 | Unknown † | Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
150 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT00653978 | Changhai-080129 | May 2008 | October 2011 | December 2011 | April 7, 2008 | June 22, 2011 |
|
|||
67 | NCT00470886 | Completed | Assessment of Compliance With Antihypertensive Telmisartan Therapy |
|
|
Observational |
|
Industry |
|
|
3400 | All | 18 Years and older (Adult, Older Adult) | NCT00470886 | 12827 KL0710PL 14237 - KL0710SK |
COAST | April 2007 | January 2010 | January 2010 | May 8, 2007 | November 16, 2012 |
|
|||
68 | NCT01616095 | Completed | Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype |
|
Observational |
|
Other |
|
|
44 | All | 21 Years to 50 Years (Adult) | NCT01616095 | GH GIIR - 2011 | GHAT | April 2011 | May 2013 | August 2015 | June 11, 2012 | April 17, 2018 |
|
||||
69 | NCT03330470 | Recruiting | Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
100 | All | 55 Years to 80 Years (Adult, Older Adult) | NCT03330470 | 15-0253 | January 1, 2017 | December 31, 2020 | December 31, 2020 | November 6, 2017 | September 17, 2018 |
|
|||
70 | NCT01388309 | Completed | An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs |
|
Observational |
|
Industry |
|
|
64 | All | 18 Years and older (Adult, Older Adult) | NCT01388309 | ML25524 | July 2011 | March 2013 | March 2013 | July 6, 2011 | November 2, 2016 |
|
|||||
71 | NCT03664544 | Recruiting | PK Study in Subjects With Severe Hepatic Impairment |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
12 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03664544 | MCI-186-E05 2018-001163-23 |
MCI-186-E05 HP | November 6, 2018 | December 2019 | December 2019 | September 10, 2018 | November 19, 2018 |
|
||
72 | NCT00169507 | Completed | Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23) |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
100 | All | 31 Months to 57 Months (Child) | NCT00169507 | 104083 | March 2005 | April 2005 | April 2005 | September 15, 2005 | May 30, 2017 |
|
|||
73 | NCT03207425 | Completed | A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
29 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03207425 | EDP 305-003 | June 14, 2017 | September 16, 2017 | September 19, 2017 | July 2, 2017 | November 6, 2017 |
|
|||
74 | NCT01110967 | Completed Has Results |
Satellite™ PEEK Nucleus Replacement Retrospective Analysis |
|
Observational |
|
Industry |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT01110967 | Satellite Retrospective | April 2010 | October 2011 | October 2011 | April 27, 2010 | January 28, 2016 | August 7, 2014 |
|
||||
75 | NCT02203448 | Completed | Facet Wedge Post Market Study |
|
|
Observational |
|
Industry |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT02203448 | CT13/01 | May 1, 2014 | August 31, 2018 | August 31, 2018 | July 30, 2014 | October 19, 2018 |
|
||||
76 | NCT02021461 | Completed Has Results |
Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
38 | All | 5 Years to 8 Years (Child) | NCT02021461 | BIA-2093-212 | December 2012 | December 2012 | December 2012 | December 27, 2013 | April 3, 2014 | April 3, 2014 |
|
||
77 | NCT01984736 | Completed | EVP-6124 Hepatic Impairment Study |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
34 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01984736 | EVP-6124-020 2012-004467-53 |
June 2013 | December 2014 | November 15, 2013 | January 15, 2015 |
|
||||
78 | NCT01509495 | Terminated | Impedance Measurements in Heart Failure Patients |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT01509495 | RAE00564 | SIM-HF | December 2011 | May 2014 | May 2014 | January 13, 2012 | July 4, 2014 |
|
||
79 | NCT01289223 | Terminated | A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab. |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
88 | All | 18 Years and older (Adult, Older Adult) | NCT01289223 | BDM3502 2010-022102-41 |
ROBIN | February 2011 | July 31, 2018 | July 31, 2018 | February 3, 2011 | September 3, 2018 |
|
||
80 | NCT01266941 | Completed | A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment. |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
35 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01266941 | 111789 | October 18, 2010 | July 15, 2011 | July 15, 2011 | December 24, 2010 | July 21, 2017 |
|
|||
81 | NCT01208285 | Completed | Study of VX-770 in Subjects With Moderate Hepatic Impairment and in Matched Healthy Subjects |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
24 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01208285 | VX10-770-013 | September 2010 | December 2010 | December 2010 | September 23, 2010 | January 12, 2011 |
|
|||
82 | NCT00437606 | Terminated | A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment. |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
2 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00437606 | NP20131 | March 2007 | June 2007 | June 2007 | February 21, 2007 | August 24, 2016 |
|
|||
83 | NCT03728764 | Recruiting | Growth and Safety of a Two-stage Feeding System in Preterm Infants |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
74 | All | up to 5 Days (Child) | NCT03728764 | 17.14.INF | October 10, 2018 | November 2019 | March 2020 | November 2, 2018 | November 2, 2018 |
|
|||
84 | NCT02210871 | Completed | Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
44 | All | 18 Years and older (Adult, Older Adult) | NCT02210871 | NN9535-3651 U1111-1149-3924 2009-011673-33 |
August 7, 2014 | June 3, 2015 | June 3, 2015 | August 7, 2014 | December 21, 2017 |
|
|||
85 | NCT02534311 | Completed | A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28) |
|
|
Observational |
|
Industry |
|
|
60 | All | 18 Years and older (Adult, Older Adult) | NCT02534311 | ML29712 | October 13, 2015 | December 1, 2015 | December 1, 2015 | August 27, 2015 | February 28, 2018 |
|
||||
86 | NCT00792909 | Completed Has Results |
Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
172 | All | 36 Months to 46 Months (Child) | NCT00792909 | 111736 | December 2, 2008 | July 2, 2009 | July 2, 2009 | November 18, 2008 | December 14, 2017 | December 14, 2017 |
|
||
87 | NCT03456349 | Completed | Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
60 | All | 55 Years to 85 Years (Adult, Older Adult) | NCT03456349 | HTL0018318-202 2017-000649-34 |
November 10, 2017 | July 16, 2018 | July 16, 2018 | March 7, 2018 | July 20, 2018 |
|
|||
88 | NCT01116089 | Completed | Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
25 | All | 18 Years and older (Adult, Older Adult) | NCT01116089 | CCD-0908-PR-0029 2009-016780-11 |
July 2010 | October 2011 | October 2011 | May 4, 2010 | November 17, 2011 |
|
|||
89 | NCT03405636 | Not yet recruiting | Xeltis Pulmonary Valved Conduit Safety and Performance Study |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
55 | All | up to 21 Years (Child, Adult) | NCT03405636 | XEL-CR-02 | June 2018 | October 2020 | October 2024 | January 23, 2018 | May 23, 2018 |
|
|||
90 | NCT02515656 | Completed Has Results |
Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis |
|
|
Interventional |
Phase 3 |
|
Industry / Other |
|
|
661 | Female | 18 Years to 64 Years (Adult) | NCT02515656 | PGX 401-11 2014-001759-22 |
PRISM | September 2015 | August 2016 | August 2016 | August 5, 2015 | January 21, 2019 | January 21, 2019 |
|
|
91 | NCT00931827 | Completed | Acceptability of Long-term Progestin-only Contraception in Europe |
|
|
Observational |
|
Industry |
|
|
436 | Female | 20 Years to 35 Years (Adult) | NCT00931827 | 14688 MA0801 14239 14177 14176 14016 |
January 2008 | November 2011 | November 2011 | July 2, 2009 | December 24, 2013 |
|
||||
92 | NCT01592500 | Completed | Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
53 | All | 3 Years to 11 Years (Child) | NCT01592500 | CP-4-004 2011-004553-60 |
February 2012 | July 2015 | July 2015 | May 7, 2012 | December 9, 2015 |
|
|||
93 | NCT01378715 | Unknown † | Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
400 | All | 18 Years and older (Adult, Older Adult) | NCT01378715 | EK-134/10 | TIPS-3 | June 2010 | June 2012 | August 2012 | June 22, 2011 | June 22, 2011 |
|
||
94 | NCT00471003 | Completed | The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension |
|
|
Observational |
|
Industry |
|
|
5448 | All | 18 Years and older (Adult, Older Adult) | NCT00471003 | 12729 KL0601PL 13929 - KL0601SI 12804 - KL0601SK 14326 - KL0601HR |
METABOLIC | September 2006 | November 2009 | November 2009 | May 8, 2007 | January 20, 2010 |
|
|||
95 | NCT00765947 | Completed Has Results |
Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
256 | All | 18 Years and older (Adult, Older Adult) | NCT00765947 | CSPP100A2360 | September 2008 | August 2009 | August 2009 | October 3, 2008 | March 11, 2011 | January 11, 2011 |
|
||
96 | NCT00196716 | Completed Has Results |
A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
21 | Male | 16 Years and older (Child, Adult, Older Adult) | NCT00196716 | AGAL-017-01 | June 2003 | April 2006 | March 2007 | September 20, 2005 | April 3, 2015 | April 2, 2009 |
|
||
97 | NCT03634748 | Completed | Thrombolysis in stRoke With Unknown onSet Based on noncontrasT CT |
|
Observational |
|
Other |
|
|
117 | All | 18 Years and older (Adult, Older Adult) | NCT03634748 | TRUST CT | TRUST CT | September 1, 2017 | December 31, 2018 | December 31, 2018 | August 16, 2018 | February 4, 2019 |
|
||||
98 | NCT01185873 | Completed | A Study of Danoprevir in Healthy Volunteers And Patients With Hepatic Impairment |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
81 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01185873 | NP25290 2010-020314-29 |
February 2011 | December 2013 | December 2013 | August 20, 2010 | November 2, 2016 |
|
|||
99 | NCT00286819 | Completed | Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
50 | Female | 18 Years to 75 Years (Adult, Older Adult) | NCT00286819 | CECOG/Breast.2.2.005 | April 2005 | September 2006 | February 6, 2006 | May 16, 2012 |
|
||||
100 | NCT01410955 | Completed | Prevention of Irinotecan Induced Diarrhea by Probiotics |
|
|
Interventional |
Phase 3 |
|
Industry / Other |
|
|
46 | All | 18 Years and older (Adult, Older Adult) | NCT01410955 | 900450001 | December 2011 | December 2013 | January 2014 | August 5, 2011 | January 23, 2014 |
|
† Study has passed its completion date and status has not been verified in more than two years.